In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 84 for your search:
Drug:  alemtuzumab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: EudraCT:2005-000805-68, NCT00354120

2.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CAM307, NCT00046683

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CAM314, 2004-000149-39, NCT00086580

5.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: PROGAST, NCT00180089

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000577580, CLL-2007-FMP, RECF0496, INCA-RECF0496, EudraCT-2007-000327-18, NCT00564512

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02807, CDR302482, CALGB 10102, U10CA031946, NCT00061945

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 12472, ACHE, BCM-H-12472, H 12472, BCM-ACHE, NCT00056966

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 0 to 70
Sponsor: Other
Protocol IDs: H8714, DIMSUM, NCT00048412

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: CDR0000370797, CALGB-100102, NCT00085449

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL3X, EU-20554, MEDAC-FLUD.10/CLL, NCT00281983

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-404, NCT00330252

13.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: TSRCC-164-2006, NCT00363090

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 55
Sponsor: NCI, Other
Protocol IDs: LCCC 0510, P30CA016086, CDR0000550145, UNC-LCCC-0510, NCT00448357

15.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL2I, CLL2I, BAYER-GCLLSG-CLL2I, EU-20816, NCT00634881

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Over 15
Sponsor: Other
Protocol IDs: P051003, NCT00773149

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MC088C, NCI-2009-00935, 08-008775, NCT00935792

18.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-0132, NCT00943319

19.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 14341B, NCT00943592

20.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: AGMT CLL-6 BendAlem, NCT00951457

21.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 to 120
Sponsor: Other
Protocol IDs: 090331, NCT00983528

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00008771 (CDR0000067374), DUMC-1340-99-7, NCI-G99-1617, NCT00004143

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067506, U10CA031946, CLB-19901, CALGB-19901, NCT00004857

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 70 and under
Sponsor: NCI, Other
Protocol IDs: 01-092, MSKCC-01092, NCI-G01-2028, NCT00027560

25.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 030194, 03-C-0194, NCI-03-C-0194, NCI-4553, 4553, NCT00064155, NCT00061048
1     
New Search